Introduction
Glomerular diseases caused by monoclonal IgG deposition include light and heavy chain deposition disease (LHCDD) (1), type 1 cryoglobulinemic glomerulonephritis (2) , immunotactoid glomerulonephritis (IT) (3) , and rarely fibrillary glomerulonephritis (FGN) (3) ( Table 1 ). LHCDD is characterized by the presence of nodular sclerosing glomerulopathy by light microscopy (LM), diffuse, linear staining of glomerular basement membranes (GBM) and tubular basement membranes (TBM) for a single heavy chain and a single light chain by immunofluorescence (IF), and nonfibrillar, "powdery", continuous electron dense deposits in GBM and TBM by electron microscopy (EM) (1) . Type 1 cryoglobulinemic glomerulonephritis exhibits a membranoproliferative or diffuse proliferative glomerulonephritis pattern on LM, usually with prominent intracapillary infiltrating monocytes and distinctive large, glassy intraluminal immune deposits (2) . Ultrastructurally, the deposits commonly show an annular-tubular or fibrillar substructure. The glomerular deposits in IT are composed of microtubular structures with a diameter of 30-50 nm and a tendency for parallel alignment, whereas in FGN they are composed of Congo red-negative, randomly-oriented fibrils measuring 16-24 nm in diameter (3). 
Diagnostic criteria for PGNMID
The following criteria are required for the diagnosis of PGNMID (4) 
Clinical features
The biopsy incidence of PGNMID was 0.17%. The disease was eight-fold rarer than AL amyloidosis and approximately twice as rare as Randall type monoclonal immunoglobulin deposition disease. The mean age at presentation was 54.5 years (range 20-81) and close to 2/3 of patients were >50 years old. There was a female predominance (female-to-male ratio of 2:1). Only 27% of patients had a monoclonal (M)-spike on Serum cryoglobulin titers were negative in all patients (performed repeatedly in many patients) and none of the patients had any systemic manifestation of cryoglobulinemia. Hypocomplementemia was present in a quarter of patients (low C3, low C4, or low C3 and C4). Rheumatoid factor, tested in 18 patients, was negative in 17 and positive in 1. Hepatitis C antibody, tested in 30 patients, was negative in 29 and positive in 1 (who had MM and normal serum complements).
At presentation, all patients had proteinuria, which was in the nephrotic range in 69% of patients, and close to a half of patients had full nephrotic syndrome.
Microhematuria was documented in 77% of patients, whereas gross hematuria was present in <3% of patients. Two thirds of patients had renal insufficiency, including 3 who were on hemodialysis. The mean serum creatinine was 2.77 mg/dl (range, 0.7-17).
Peripheral edema was present in 62% of patients.
Pathologic features
On LM, the glomerular alterations were heterogeneous, with the majority of On EM, the deposits were confined to the glomerular compartment, present primarily in the mesangium and subendothelial space. Subepithelial deposits were less frequent, seen in 57% of patients, and were segmental in most cases.
In 70% of cases, the electron dense deposits had a finely granular texture throughout, without substructure, resembling immune-complex type glomerulonephritis.
In the remaining 30% of cases, the deposits were mostly granular, but with focally variegated texture. Rarely, ill-defined fibrils measuring <12 mm in diameter and focal organization into lattice-like arrays with a periodicity of 15 nm were seen involving a portion of otherwise granular deposits.
Treatment and outcome
Most patients were treated with steroids alone or in combination with other immunosuppressive agents, whereas some were treated with renin angiotensin system 
Etiology and pathogenesis
The pathogenesis of PGNMID remains elusive. The absence of underlying infectious, autoimmune, or other systemic disease in the vast majority of patients and the light chain and heavy chain subclass restriction argue against antigen-antibody immune complex deposition and, instead, favor that monoclonal IgG is deposited as a free, noncomplexed immunoglobulin, which has the ability to aggregate to form definable dense deposits. Because up to 2/3 of patients have no detectable M protein (by standard SPEP/UPEP/IFE) even after long follow-up, in these cases we propose that this unique glomerulonephritis may arise in the course of normal immune responses. It is possible that during an immune response (to extrinsic or intrinsic antigens), a clone of B-cells proliferates and produces a monoclonal IgG molecule (particularly IgG3) with ability to self-aggregate and rapidly deposit in glomeruli through entrapment and/or interaction with negatively charged glomerular constituents. The small quantity of this monoclonal IgG may elude detection in by SPEP/UPEP/IFE due to its high avidity for the glomeruli and rapid aggregability favored by its intrinsic physical properties and glomerular sieving itself.
Human IgG is divided into four subclasses that differ in their heavy chain structure, molecular weight, concentration in the serum, isoelectric point (pI), and immunogenicity. Of the 4 subclasses, IgG3, which comprises only 8% of IgG in the circulation, has several properties that allow it to be intrinsically "nephritogenic" (11, 12) . (1) In contrast to heavy chain deposition disease in which the CH1 constant domain is deleted, using monoclonal antibodies to epitopes of the constant domains of IgG heavy chains, we found no detectable deletion in any of the constant domains in PGNMID (4).
The intact CH2 domain is essential for complement fixation. Amino acid sequencing of glomerular deposits in PGNMID is needed to determine whether there are unique amino acid substitutions in the heavy or light chains that may increase the pI or hydrophobicity of IgG molecules, which could promote the propensity for self-aggregation and glomerular deposition, as has been reported in Randall-type light chain deposition disease (15) .
Conclusions
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PGNMID is a novel form of glomerulonephritis that mimics immune-complex type glomerulonephritis on LM and EM. However, by IF, the glomerular deposits are monoclonal, staining for a single light chain isotype and a single gamma heavy chain subclass, most commonly IgG3 kappa. Despite the monoclonality, few patients have a detectable serum M-spike, and hematologic malignancy is rare. Furthermore, PGNMID does not appear to represent a premyelomatous condition. The disease affects adults and is more common in females. Most patients present with nephrotic-range proteinuria and hematuria with or without renal insufficiency. Prognosis is variable, with nearly a quarter of patients progressing to ESRD within 2.5 years despite immunomodulatory therapy.
